Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-222-5 | CAS number: 1314-13-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Zinc oxide
- EC Number:
- 215-222-5
- EC Name:
- Zinc oxide
- Cas Number:
- 1314-13-2
- Molecular formula:
- ZnO
- IUPAC Name:
- oxozinc
- Test material form:
- solid: nanoform
- Details on test material:
- - Name of test material (as cited in study report): Z-Cote HP1
- Substance type: ZnO nanoscaled coated on its surface with Triethoxycaprylylsilane (CAS # 2943-75-1)
- Physical state:solid, homogenous
- Lot/batch No.: CNHK1402
- Expiration date of the lot/batch: 30 Sep 2013
- Stability under test conditions: The stability of the test substance under storage conditions over the test period was guaranteed by the sponsor, and the sponsor holds this responsibility.
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH
- Age at study initiation: 11 -14 weeks
- Weight at study initiation: 146.0 - 192.1 g
- Fasting period before study: no
- Housing: individually, dust-free wooden bedding, enrichment: wooden gnawing blocks
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%.
- Air changes (per hr): 15/h
- Photoperiod (hrs dark / hrs light): 12h/12h
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure (if applicable):
- nose/head only
- Vehicle:
- air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: flow-past nose-only exposure system, individually exposure of each rat, exhaled air is immediately exhausted
- Method of holding animals in test chamber: individual acrylic tubes
- Source and rate of air: conditioned and compressed air, 6 m3/h
- System of generating particulates/aerosols: feeding system and high-pressure, high-velocity pressurized air dispersion with computerized control
- Temperature, humidity, pressure in air chamber: 22 +/- 2°C, 50 +/- 20%,
- Air flow rate: 6 m3/h
- Method of particle size determination: cascade impactor/ Marple impactor
- Treatment of exhaust air: disposal in compliance with local, federal and state regulations
TEST ATMOSPHERE
- Brief description of analytical method used: gravimetrically by filter samples
- Samples taken from breathing zone: yes - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentrations of the inhalation atmospheres of test group 1 – 3 were analyzed by gravimetrical analysis. Daily means were calculated based on two measured samples per concentration and exposure. From the daily mean values of each concentration, mean concentrations and standard deviations for the entire study were derived. In these groups, the constancy of concentration in each inhalation system was continuously monitored using scattered light photometers.
In the control group (test group 0) no sample was analyzed over the study period. The analyses were carried out at the Inhalation Laboratory of the Experimental Toxicology and Ecology of BASF SE. - Details on mating procedure:
- The animals were paired by the breeder (“time-mated”) and supplied on GD 0 (= detection of vaginal plug/sperm). The animals arrived on the same day (GD 0) at the experimental laboratory.
- Duration of treatment / exposure:
- 6 hours on 14 consecutive days
- Frequency of treatment:
- daily
- Duration of test:
- from implantation to one day prior to the expected day of parturition
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.3 mg/m³ air
- Dose / conc.:
- 1.5 mg/m³ air
- Dose / conc.:
- 7.5 mg/m³ air
- No. of animals per sex per dose:
- 25 pregnant females per dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: request of the sponsor
- Rationale for animal assignment: random
The inhalation route was selected since it is relevant in terms of potential human exposure.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice a day
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: at least once a day
BODY WEIGHT: Yes
- Time schedule for examinations: All animals were weighed on gestation day (GD) 0, 1, 3, 6, 8, 10, 13, 15, 17, 19 and 20.
The corrected body weight gain was calculated after terminal sacrifice (terminal body weight on GD 29 minus weight of the unopened uterus minus body weight on GD 6).
FOOD CONSUMPTION
The consumption of food was recorded for GD 1-3, 3-6, 6-8, 8-10, 10-13, 13-15, 15-17, 17-19 and 19-20.
POST-MORTEM EXAMINATIONS: Yes / No / No data
- Sacrifice on gestation day #20
- Organs examined: Organ weights of the lungs, the unopened uterus and the placentas were determined. For each dam, corpora lutea were counted and number and distribution of implantation sites (differentiated by resorptions, live and dead fetuses) were determined. The fetuses were removed from the uterus, sexed, weighed and further investigated for external, soft tissue and skeletal (incl. cartilage) findings. Larynx, lungs, mediastinal and tracheobronchial lymph nodes, trachea and nasal cavities were examined histopathologically in the control and high-dose groups. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: Yes: all per litter
- Skeletal examinations: Yes: all per litter
- Head examinations: Yes: all per litter - Statistics:
- clinical and fetal examination:
Simultaneous com-parison of all dose groups with the control group using the DUNNETT-test (two-sided) for the hypothesis of equal means
Pairwise comparison of each dose group with the control group using FISHER'S EXACT test (one-sided) for the hypothesis of equal proportions
Pairwise comparison of each dose group with the control group using the WILCOXON-test (one-sided) for the hypothesis of equal medians
Pathology:
Non-parametric one-way analysis using KRUSKAL-WALLIS test (two-sided). If the resulting p-value was equal or less than 0.05, a pairwise comparison of each dose group with the control group was performed using the WILCOXON test for the hypothesis of equal medians - Historical control data:
- used to interprete results of present study
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEC
- Effect level:
- 1.5 mg/m³ air
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEC
- Effect level:
- 7.5 mg/m³ air
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
no effects observed
Effect levels (fetuses)
- Dose descriptor:
- NOAEC
- Effect level:
- 7.5 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- changes in sex ratio
- fetal/pup body weight changes
- changes in litter size and weights
- external malformations
- skeletal malformations
- visceral malformations
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
The following test substance-related adverse effects/findings were noted:
Test group 3 (7.5 mg/m3):
· Increase in absolute and relative lung weights (up to 47%)
· Moderate alveolar lipoproteinosis in all animals examined
· Slight, diffuse inflammation in all animals examined
· Minimal to slight focal hemorrhage in three of ten animals
· No test substance-related adverse effects on gestational parameters or fetuses
Test group 2 (1.5 mg/m3):
· No test substance-related adverse effects on dams, gestational parameters or fetuses
Test group 1 (0.3 mg/m3):
· No test substance-related adverse effects on dams, gestational parameters or fetuses
Applicant's summary and conclusion
- Executive summary:
Under the conditions of this prenatal developmental toxicity study, the inhalative administration of Z-Cote HP1 to pregnant Wistar rats from implantation to one day prior to the expected day of parturition (GD 6-19) at a dose of 7.5 mg/m³ caused moderate alveolar lipoproteinosis and slight inflammation. These histopathologic findings are regarded to be adverse in nature. The relevance for humans however is not clear.
In conclusion, the no observed adverse effect concentration (NOAEC) for maternal toxicity is1.5 mg/m³.
The no observed adverse effect concentration (NOAEC) for prenatal developmental toxicity is7.5 mg/m³.There were no adverse fetal findings evident at any dose.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.